Skip to main content
. 2018 Jan 24;52(3):815–827. doi: 10.3892/ijo.2018.4252

Table I.

The basic information of 20 patients with ovarian serous cystadenocarcinoma for miR-149-5p expression analysis.

Characteristic Cases (n) Percentage
Age (years)
 <55 6 30
 ≥55 14 70
Stage
 Stage I 1 5
 Stage II 1 5
 Stage III 14 70
 Stage IV 4 20
Grade
 G1 0 0
 G2 3 15
 G3 17 85
Treatment
 Complete response 10 50
 Partial response 1 5
 Stable disease 3 15
 Progressive disease 6 30